About the Product

Description


Ticotyle 200 Injection contains Teicoplanin (200 mg), a broad-spectrum glycopeptide antibiotic used to treat severe bacterial infections caused by Gram-positive bacteria. It is particularly effective against methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus species, making it a preferred choice in serious infections where other antibiotics may not be effective.

Teicoplanin works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death. It is commonly used in bone and joint infections, respiratory tract infections, skin and soft tissue infections, urinary tract infections, endocarditis, and septicemia. Due to its long half-life, Ticotyle 200 Injection allows for once-daily dosing, improving patient compliance and reducing hospital visits.

This injection is administered intravenously (IV) or intramuscularly (IM) under medical supervision, ensuring optimal absorption and effectiveness. It is a well-tolerated antibiotic, with a lower risk of kidney toxicity compared to other glycopeptides like vancomycin.

Common side effects may include dizziness, drowsiness, nausea, dry mouth, or constipation. Consult your healthcare provider if any severe reactions occur.

Pregahike D 75/30 Capsule is indicated for the treatment of neuropathic pain, generalized anxiety disorder, and fibromyalgia.

Pregahike D 75/30 Capsule should be used under medical supervision, especially in patients with a history of seizures, liver or kidney problems.

Store in a cool, dry place, away from direct sunlight. Keep the container tightly closed to maintain product quality.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions